Analyst firms · Morgan Stanley · GLPG
Morgan Stanley GLPG price target and rating history
Galapagos NV (GLPG) · Health Care
Morgan Stanley rates Galapagos NV (GLPG) Underweight with a $22 price target, as of its latest action on Feb 14, 2025. It has published 5 rating actions on GLPG since January 2022, including 0 upgrades and 2 downgrades.
- Current rating
- Underweight
- Price target
- $22
- Median target, all firms
- Too few
- Actions on GLPG
- 5
Morgan Stanley price target on GLPG
Every Morgan Stanley rating on GLPG
- Feb 14, 2025
- Mar 7, 2024
- Sep 9, 2022
- Feb 28, 2022
- Jan 6, 2022
Questions about Morgan Stanley and GLPG
- What is Morgan Stanley's price target for GLPG?
- Morgan Stanley's latest stated price target for Galapagos NV (GLPG) is $22, from its action on Feb 14, 2025.
- What is Morgan Stanley's rating on GLPG?
- Morgan Stanley rates GLPG Underweight, a bearish rating, as of Feb 14, 2025.
- When did Morgan Stanley last change its view on GLPG?
- On Feb 14, 2025, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $31 to $22.
More GLPG rating histories
All Morgan Stanley ratingsGLPG news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.